Astellas Submits New Drug Application for Zolbetuximab in Japan
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA)...
Stay updated with breaking news from Interim Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA)...
– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approach to a functional cure for HBV – SAN... | June 7, 2023
Company announcement no. 4 2023 Danske Bank A/SHolmens Kanal 2 – 12DK-1092 København KTel. +45 45 14 00 007 June 2023 Danske Bank announces its new Forward ‘28 strategy and... | June 7, 2023
Two Indigenous PhD scholarships funded by Rotary will help build capacity in chronic disease prevention in Indigenous communities.
Oldfields School is the subject of a lawsuit as a parent attempts to get the court to keep the Baltimore County school open.